Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Corrigendum to "Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: presentation and outcomes of adults at a single center" [J. Neuroimmunol. 2022, Article 577987].
Journal: Journal of neuroimmunology
Published: September 06, 2026
Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis.
Journal: Journal of medical economics
Published: June 21, 2026
Clinical Reasoning: A 28-Year-Old Man With Seizures and Thalamic Lesions.
Journal: Neurology
Published: May 08, 2026
Beyond biopsy for neurosarcoidosis: A review of blood and CSF biomarkers.
Journal: Journal of neuroimmunology
Published: April 03, 2024
Adalimumab as treatment for neurosarcoidosis: A case series.
Journal: Journal of the neurological sciences
Published: January 08, 2024
Neurosarcoidosis causing hydrocephalus: A case series.
Journal: Journal of neuroimmunology
Published: March 08, 2023
Steroid-induced weight gain in the treatment of neurosarcoidosis.
Journal: Multiple sclerosis and related disorders
Published: November 21, 2022
Neuromyelitis optica: Clinical course and potential prognostic indicators.
Journal: Multiple sclerosis and related disorders
Published: July 23, 2022
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center.
Journal: Journal of neuroimmunology
Published: July 01, 2022
Leber's Hereditary Optic Neuropathy Plus Causing Recurrent Myelopathy due to an MT-DN1 Mutation at G3635A.
Journal: Case reports in neurological medicine
Published: July 30, 2021
Last Updated: 09/26/2026